Research ArticleHEALTH AND MEDICINE

LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance

See allHide authors and affiliations

Science Advances  10 Feb 2021:
Vol. 7, no. 7, eabb3555
DOI: 10.1126/sciadv.abb3555

Article Information

vol. 7 no. 7

PubMed: 
Online ISSN: 
History: 
  • Received for publication February 18, 2020
  • Accepted for publication December 23, 2020
  • .

Author Information

  1. Weiwei Guo1,*,
  2. Yue Wang1,*,
  3. Min Yang2,*,
  4. Zehua Wang1,
  5. Yifei Wang1,
  6. Smriti Chaurasia3,4,
  7. Zhiyuan Wu1,
  8. Min Zhang1,
  9. Ghanshyam Singh Yadav3,4,
  10. Sanjay Rathod1,
  11. Fernando Concha-Benavente2,3,
  12. Christian Fernandez1,
  13. Song Li1,
  14. Wen Xie1,
  15. Robert L. Ferris2,3,
  16. Udai S. Kammula3,4,
  17. Binfeng Lu2 and
  18. Da Yang1,3,5,
  1. 1Center for Pharmacogenetics, Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  2. 2Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  3. 3UPMC Hillman Cancer Institute, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  4. 4Division of Surgical Oncology, Department of Surgery, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.
  5. 5Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
  1. Corresponding author. Email: dyang{at}pitt.edu
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: February 2021 to April 2021

AbstractFullPdf
Feb 20212302975989
Mar 2021491044268
Apr 20212425079

Stay Connected to Science Advances

Navigate This Article